Talc's Contamination Risk Is a Formulation Liability. White Sapphire® Is Your Solution.

• Regulators have moved fast in response. Talc is now classified Category 1B by ECHA and Group 2A by IARC, and the EU is heading toward an automatic cosmetics ban around 2027.

• The liability is already material. FDA testing has found asbestos in cosmetic talc products, and Johnson & Johnson has reserved approximately $11 billion against talc litigation.

• Talc and asbestos form in the same deposits. Every batch carries a testing burden that can never be fully engineered away.

• White Sapphire® removes the risk at its source. As a manufactured ingredient, it carries no asbestos cross-contamination risk, and it delivers comparable mattifying and adhesion performance to talc in colour cosmetic and suncare systems.

• White Sapphire® carries independent verification. It is CIR-reviewed as safe, FDA-approved, COSING-listed, and holds third-party EcoCert COSMOS v4 certification, unlike talc's shifting and contested safety status.

---

Talc's Regulatory and Legal Exposure Is Growing

Talc's regulatory position has shifted fast. In September 2024, ECHA's Committee for Risk Assessment classified talc as a Category 1B carcinogen, a designation that automatically triggers a cosmetics ban under EU Regulation 1223/2009, expected around 2027 (European Chemicals Agency, 2024). In July 2024, IARC upgraded talc to Group 2A, "probably carcinogenic to humans" (International Agency for Research on Cancer, 2024). Recently, Johnson & Johnson has now set aside approximately $11 billion to cover talc litigation, with more than 68,000 claims pending in a single US court (Sokolove Law, 2026).

---

Why talc carries a contamination risk that can't be engineered away

Talc and asbestos form under the same metamorphic conditions and are frequently found in the same deposits. The US EPA (2024) notes that talc mined from asbestos-bearing ore can carry asbestos fibre contamination into the resulting mineral. This isn't a processing failure. It's a feature of where talc comes from, and it means every batch carries a testing burden that never fully disappears.

That risk isn't theoretical. FDA testing found asbestos in 9 of 52 cosmetic products (US Food and Drug Administration, 2020), triggering a recall of Johnson's Baby Powder after chrysotile asbestos was confirmed in a single lot. A peer-reviewed EWG-commissioned study found amphibole asbestos in 3 of 21 talc-based cosmetics tested, a 14% contamination rate, including one product marketed as a children's toy makeup kit (Stoiber, Fitzgerald, & Leiba, 2020). Peer-reviewed case series have linked cosmetic talc exposure to mesothelioma in patients with no other identified asbestos exposure (Emory, Maddox, & Kradin, 2020; Moline et al., 2020). Research examining talc use and ovarian cancer has found a positive association. A case-control meta-analysis found that perineal talc use is linked to an increased risk of ovarian cancer (Penninkilampi & Eslick, 2018), adding to the health concerns already driving formulators away from talc.

The uncertainty this creates is now a formulation liability in its own right. Even asbestos-free talc is swept into the EU's Category 1B classification, and the US currently has no mandatory testing rule after the FDA withdrew its proposed 2024 rule in November 2025 (Environmental Working Group, 2025). Brands are left carrying the reputational and legal exposure of an ingredient they can't fully control at the source.

---

Where White Sapphire® changes the equation

White Sapphire® has been deemed safe for cosmetic use. It's approved by the FDA as a color additive and listed in the EU's COSING database. It also holds independent EcoCert COSMOS v4 certification, verified through a third-party conformity attestation rather than a manufacturer's own claim.

For formulators seeking a talc alternative, Advance ZincTek’s internal testing exemplifies this: White Sapphire® not only matches or exceeds talc’s mattifying and adhesion performance in colour cosmetics and sun care formulations, but does so without the regulatory and sourcing uncertainty now associated with talc.

---

References

Becker, L. C., Boyer, I., Bergfeld, W. F., Belsito, D. V., Hill, R. A., Klaassen, C. D., Liebler, D. C., Marks, J. G., Shank, R. C., Slaga, T. J., Snyder, P. W., & Andersen, F. A. (2016). Safety assessment of alumina and aluminum hydroxide as used in cosmetics. International Journal of Toxicology, 35(3 Suppl.).

Emory, T. S., Maddox, J. C., & Kradin, R. L. (2020). Malignant mesothelioma following repeated exposures to cosmetic talc: A case series of 75 patients. American Journal of Industrial Medicine, 63(6), 484-489.

Environmental Working Group. (2025, November). FDA withdraws rule on tests for cancer-causing asbestos in talc-based cosmetics.

European Chemicals Agency. (2024). RAC opinion on the harmonised classification of talc.

International Agency for Research on Cancer. (2024, July 5). IARC Monographs evaluate the carcinogenicity of talc and acrylonitrile (Press Release No. 352).

Moline, J., Bevilacqua, K., Alexandri, M., & Gordon, R. E. (2020). Mesothelioma associated with the use of cosmetic talc. Journal of Occupational and Environmental Medicine, 62(1), 11-17.

O'Brien, K. M., Tworoger, S. S., Harris, H. R., Anderson, G. L., Weinberg, C. R., Trabert, B., Kaunitz, A. M., D'Aloisio, A. A., Sandler, D. P., & Wentzensen, N. (2020). Association of powder use in the genital area with risk of ovarian cancer. JAMA, 323(1), 49-59.

Penninkilampi, R., & Eslick, G. D. (2018). Perineal talc use and ovarian cancer risk. Epidemiology, 29(1), 41-49.

Sokolove Law. (2026). Talcum powder settlement amounts & verdicts.

Stoiber, T., Fitzgerald, S., & Leiba, N. S. (2020). Asbestos contamination in talc-based cosmetics: An invisible cancer risk. Environmental Health Insights, 14.

U.S. Environmental Protection Agency. (2024). Risk evaluation for asbestos.

U.S. Food and Drug Administration. (2020, March 9). FDA advises consumers to stop using certain cosmetic products (Cosmetics Constituent Update).